James Chung
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About James Chung
Kyverna Therapeutics, Inc. reported in an 8-K filed November 26, 2024 that James Chung resigned as Chief Medical Officer, effective November 22, 2024. Kyverna Therapeutics, Inc. reported in an 8-K filed November 13, 2024 that James Chung resigned as Chief Medical Officer, effective November 22, 2024. The proxy statement of Kyverna Therapeutics, Inc. reports total compensation of $624,576 for James Chung in fiscal 2024, including a base salary of $404,576. Disclosed compensation is on record for 2 fiscal years.
“James Chung, M.D., Ph.D., Chief Medical Officer of Kyverna Therapeutics, Inc. (the "Company"), resigned from the Company, to be effective as of November 22, 2024.”
“On November 8, 2024, James Chung, M.D., Ph.D., Chief Medical Officer of the Company, resigned from the Company, to be effective as of November 22, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Kyverna Therapeutics, Inc. (KYTX)
Proxy statement
Start not stated–2024-11-22
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Kyverna Therapeutics, Inc. (KYTX) | M.D., Ph.D. Former Chief Medical Officer | $404,576 | $624,576 |
| 2023 | Kyverna Therapeutics, Inc. (KYTX) | M.D., Ph.D. Former Chief Medical Officer | $401,995 | $1,166,122 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.